Research Use Only - Not for human consumption. 18+ only.
Clinical TrialsCosmetic & TopicalTopical

Melanostatin DM

A melanin synthesis inhibitor for skin brightening. Reduces hyperpigmentation with a gentle, long-term safety profile.

Research Status

Clinical Trials

Limited Clinical Data

For research purposes only. Not approved for human use. Not medical advice.

Research Areas

Reduces melanin production and hyperpigmentation
Brightens skin tone and evens complexion
Inhibits tyrosinase enzyme activity
Supports long-term skin lightening effects
Gentle alternative to harsh depigmenting agents

Side Effects

Mild skin irritation or erythema
UncommonMild

May occur with initial application or in sensitive individuals. Usually resolves within 1-2 weeks of continued use. Reduce frequency to 1x daily if irritation persists.

Dryness or tightness
UncommonMild

Topical peptides can occasionally cause mild dryness. Use a hydrating moisturizer after application. Ensure adequate hydration.

Contact dermatitis or allergic reaction
RareModerate

Possible in individuals with peptide sensitivity. Perform a patch test on a small area (e.g., inner arm) 24-48 hours before full application. Discontinue if rash, swelling, or itching develops.

Photosensitivity or increased UV sensitivity
RareModerate

Some depigmenting agents may increase photosensitivity. Use broad-spectrum SPF 30+ sunscreen daily during treatment. Avoid prolonged sun exposure.

Uneven depigmentation or patchy lightening
UncommonMild

May occur if application is inconsistent or uneven. Ensure thorough, uniform coverage of affected areas. Results typically appear after 4-8 weeks of consistent use.

Dosing Reference

ParameterValue
Dose range1-3 %
Frequency1-2x daily
TimingMorning and/or evening skincare routine
RouteTopical

Topical application only. Start with 1% concentration and assess tolerance before increasing. For research purposes only.

Research disclaimer

Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution Guide

Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution

Do not shake the vial vigorously; gentle swirling prevents peptide degradation

Discard immediately if the solution appears cloudy, discolored, or contains visible particles

Use within 30 days of reconstitution when stored at 2–8°C

Do not freeze the reconstituted solution; freezing may denature the peptide

Use the PeptideVolt reconstitution calculator for your exact concentration

Use the PeptideVolt reconstitution calculator for your exact concentration

Molecular and Pharmacological Data

Melanostatin DM inhibits melanin synthesis by suppressing tyrosinase enzyme activity, the rate-limiting enzyme in the melanin biosynthetic pathway. By reducing the conversion of L-tyrosine to dopaquinone, it decreases melanin production in melanocytes, leading to gradual skin brightening and reduction of hyperpigmentation. The peptide works through sustained inhibition rather than acute melanocyte destruction, supporting a gentle, reversible mechanism.

Tyrosinase Inhibition

Melanostatin DM directly or allosterically inhibits tyrosinase, the copper-dependent enzyme that catalyzes the first two steps of melanin synthesis (L-tyrosine to L-DOPA, and L-DOPA to dopaquinone). Reduced tyrosinase activity decreases overall melanin production.

Melanin Biosynthetic Pathway Suppression

By blocking early steps in the eumelanin and pheomelanin synthesis pathways, the peptide reduces the accumulation of melanin granules (melanosomes) within melanocytes, resulting in lighter skin tone over time.

Melanocyte Signaling Modulation

The peptide may modulate intracellular signaling pathways (e.g., cAMP, MAPK) that regulate melanin production, reducing the responsiveness of melanocytes to UV exposure and inflammatory stimuli.

  • Tyrosinase is the rate-limiting enzyme in melanin synthesis; inhibition reduces melanin production at the source
  • Topical application allows direct delivery to melanocytes in the epidermis with minimal systemic absorption
  • Mechanism is reversible — melanin production resumes if treatment is discontinued
  • Efficacy depends on consistent application and sun protection to prevent new melanin formation

Track your Melanostatin DM research

Free account. No credit card required.

Start Free

Browse the Research Library

40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.

View all peptides

Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Melanostatin DM is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.